2007 Annual Meeting | Update on Multiple Sclerosis

Date Friday 05/04/07

Time 09:00 AM - 05:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Full-Day Course

Director(s) Claudia F. Lucchinetti, MD, FAAN

Topic(s)

Learning Objectives Upon Completion:
Participants should be able to understand the pathology, pathogenesis, imaging, epidemiology, diagnostic criteria, and management of patients with pediatric and adult MS; receive an update on future research directions; and have an opportunity to apply their knowledge to specific case scenarios.

CME Available No CME available

Core Competencies Medical Knowledge, Practice-based Learning and Improvement

Program Level Advanced

Recommended Audience Practitioner, Fellow, Academician, Nurse

Event Timeline
09:00 AM - 09:05 AM		Introduction and Course Overview Claudia F. Lucchinetti, MD, FAAN
09:05 AM - 09:45 AM		Taking a Microscopic Look at MS: Pathogenic and Clinical Implications Claudia F. Lucchinetti, MD, FAAN
09:45 AM - 09:50 AM		Questions and Answers
09:50 AM - 10:30 AM		Neuroimaging: Update in Multiple Sclerosis David H. Miller, MD, MBChB, FRCP
10:30 AM - 10:35 AM		Questions and Answers David H. Miller, MD, MBChB, FRCP
10:35 AM - 10:50 AM		Break
10:50 AM - 11:30 AM		Epidemiology of MS: Can MS be Prevented? Alberto Ascherio, MD, PhD
11:30 AM - 11:35 AM		Questions and Answers Alberto Ascherio, MD, PhD
11:35 AM - 01:00 PM		Lunch
01:00 PM - 01:40 PM		Diagnosis: From McDonald and Beyond Brian G. Weinshenker, MD, FAAN
01:40 PM - 01:45 PM		Questions and Answers Brian G. Weinshenker, MD, FAAN
01:45 PM - 02:25 PM		The Youngest Teachers-Lessons Learned in Pediatric MS Brenda L. Banwell, MD, FAAN
02:25 PM - 02:30 PM		Questions and Answers Brenda L. Banwell, MD, FAAN
02:30 PM - 03:25 PM		Rational Therapeutic Strategies Dean M. Wingerchuk, MD, FAAN
03:25 PM - 03:30 PM		Questions and Answers Dean M. Wingerchuk, MD, FAAN
03:30 PM - 03:45 PM		Break
03:45 PM - 04:25 PM		The Future of MS Therapeutics: To Immunity and Beyond Richard M. Ransohoff, MD
04:25 PM - 04:30 PM		Questions and Answers Richard M. Ransohoff, MD
04:30 PM - 05:00 PM		Interactive Case Studies

Faculty Disclosures
Claudia F. Lucchinetti, MD, FAAN	The institution of Dr. Lucchinetti has received research support from Biogen Idec. The institution of Dr. Lucchinetti has received research support from NIH/NINDS. The institution of Dr. Lucchinetti has received research support from National Institute of Neurological Disorders and Stroke . The institution of Dr. Lucchinetti has received research support from National Multiple Sclerosis Society. The institution of Dr. Lucchinetti has received research support from National Center for Advancing Translational Sciences. Dr. Lucchinetti has received intellectual property interests from a discovery or technology relating to health care. Dr. Lucchinetti has a non-compensated relationship as a Member with National Institute of Neurological Disorders that is relevant to AAN interests or activities. Dr. Lucchinetti has a non-compensated relationship as a Member with Board of Directors, Association of University Professors of Neurology that is relevant to AAN interests or activities. Dr. Lucchinetti has a non-compensated relationship as a Member with Mayo Clinic Board of Trustees that is relevant to AAN interests or activities. Dr. Lucchinetti has a non-compensated relationship as a Member with Mayo Clinic Board of Governors that is relevant to AAN interests or activities.
Brenda L. Banwell, MD, FAAN	Dr. Banwell has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Banwell has received personal compensation in the range of $0-$499 for serving as a Consultant for UCB. Dr. Banwell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Banwell has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Banwell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Banwell has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Banwell has received research support from National MS Society. The institution of Dr. Banwell has received research support from NIH.
Brian G. Weinshenker, MD, FAAN	Dr. Weinshenker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CANbridge Pharmaceuticals. Dr. Weinshenker has received personal compensation in the range of $0-$499 for serving as a Consultant for CALIBR. Dr. Weinshenker has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon. Dr. Weinshenker has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Weinshenker has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Group (Chugai, Genentech, Roche). Dr. Weinshenker has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharmaceuticals. Dr. Weinshenker has received research support from Guthy Jackson Charitable Foundation. Dr. Weinshenker has received intellectual property interests from a discovery or technology relating to health care.
Dean M. Wingerchuk, MD, FAAN	Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imcyse. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TTY Biopharm. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Reistone Biopharm. Dr. Wingerchuk has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. Dr. Wingerchuk has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Wingerchuk has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Meyer Squibb. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Wingerchuk has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca. Dr. Wingerchuk has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abcuro. Dr. Wingerchuk has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters Kluwers.
Richard M. Ransohoff, MD	Dr. Ransohoff has received personal compensation for serving as an employee of Third Rock Ventures. Dr. Ransohoff has stock in Biogen. Dr. Ransohoff has received intellectual property interests from a discovery or technology relating to health care.
David H. Miller, MD, MBChB, FRCP	No disclosure on file
Alberto Ascherio, MD, PhD	The institution of Dr. Ascherio has received research support from NIH and US Department of Defense .

��ɫ��

��ɫ��